| RS35821434 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex with nail dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2Q |
| RS35823417 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, IFT140-related disorder |
| RS35826988 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS35829419 |
NLRP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 1, Chronic infantile neurological |
| RS35831931 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS35837567 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS35840595 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS35843015 |
MARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency, Charcot-Marie-Tooth disease axonal type 2U |
| RS35846833 |
DNMT3B
|
Health Risk |
Conflicting classifications of pathogenicity |
Centromeric instability of chromosomes 1, 9 and 16 and immunodeficiency |
| RS35849199 |
HBB
|
Health Risk |
Pathogenic; other |
Heinz body anemia, HEMOGLOBIN INDIANAPOLIS |
| RS35849348 |
HBD
|
Health Risk |
Pathogenic |
HEMOGLOBIN A(2) BABINGA, HEMOGLOBIN A(2) BABINGA |
| RS35852516 |
STAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS35853292 |
KCNA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary hypertension, primary |
| RS35855065 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS35855196 |
SLC12A6
|
Health Risk |
Conflicting classifications of pathogenicity |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS35856689 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS35857380 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS35857705 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dilated cardiomyopathy 1O |
| RS35859650 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, Muscle AMP deaminase deficiency |
| RS35861510 |
HOXA13
|
Health Risk |
Pathogenic/Likely pathogenic |
Hand-foot-genital syndrome, Hand-foot-genital syndrome |
| RS35865357 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS35865691 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS35867418 |
NUBPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS35868965 |
TCOF1
|
Health Risk |
Pathogenic |
Treacher Collins syndrome 1, Treacher Collins syndrome 1 |
| RS35869497 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS35870237 |
LRRK2
|
Health Risk |
Pathogenic |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS35870543 |
ZNF280B
|
Health Risk |
Conflicting classifications of pathogenicity |
Exstrophy-epispadias complex, Exstrophy-epispadias complex |
| RS35873579 |
CYP24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercalcemia, infantile |
| RS35874056 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35878526 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS35878954 |
SLC2A1
|
Health Risk |
Pathogenic |
— |
| RS35881692 |
DOCK6
|
Health Risk |
Conflicting classifications of pathogenicity |
DOCK6-related disorder, Inborn genetic diseases |
| RS35885472 |
ALDOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary fructosuria, ALDOB-related disorder |
| RS35887009 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS35887327 |
HSD3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
3 beta-Hydroxysteroid dehydrogenase deficiency, HSD3B2-related disorder |
| RS35887507 |
HBD
|
Health Risk |
Pathogenic |
Delta-0-thalassemia, Delta-0-thalassemia |
| RS35887622 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 1A, Nonsyndromic genetic hearing loss |
| RS35890959 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
HEMOGLOBIN OLYMPIA, Erythrocytosis |
| RS35891605 |
PRKCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune lymphoproliferative syndrome, type III caused by mutation in PRKCD |
| RS35891845 |
SLC4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive proximal renal tubular acidosis, Autosomal recessive proximal renal tubular acidosis |
| RS35892240 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS35894115 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS35896485 |
GFI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neutropenia, severe congenital |
| RS35897051 |
LPO;MPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Myeloperoxidase deficiency, MPO-related disorder |
| RS35898499 |
MERTK
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa 38 |
| RS35900050 |
CYP19A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aromatase deficiency, Aromatase deficiency |
| RS35902379 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS35904234 |
TRIM32
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS35909818 |
HSPB8
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2L, Inborn genetic diseases |
| RS35915872 |
LTBP2
|
Health Risk |
Pathogenic |
— |
| RS35916840 |
TTPA
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial isolated deficiency of vitamin E, Gastric cancer |
| RS35918369 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer, EGFR-related lung cancer |
| RS35925274 |
ARHGEF10
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant slowed nerve conduction velocity, Autosomal dominant slowed nerve conduction velocity |
| RS35925435 |
RIMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35926225 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS35932623 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
WFS1-Related Spectrum Disorders, Autosomal dominant nonsyndromic hearing loss 6 |
| RS35939430 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
HEMOGLOBIN CRETE, beta Thalassemia |
| RS35939489 |
HBB
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN CHICO, HEMOGLOBIN CHICO |
| RS35942383 |
RCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS35942532 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, LRP2-related disorder |
| RS35946687 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS35946774 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Inborn genetic diseases |
| RS35947132 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
Hemophagocytic lymphohistiocytosis, familial |
| RS35949130 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
BETA-PLUS-THALASSEMIA, beta Thalassemia |
| RS35952153 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS35956074 |
LIG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS35957013 |
CFHR5
|
Health Risk |
Conflicting classifications of pathogenicity |
C3 glomerulonephritis, C3 glomerulonephritis |
| RS35957924 |
TSFM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS35959882 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Inborn genetic diseases |
| RS35960628 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS35960726 |
HAVCR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Subcutaneous panniculitis-like T-cell lymphoma, Subcutaneous panniculitis-like T-cell lymphoma |
| RS35962982 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS35963362 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Autosomal recessive nonsyndromic hearing loss 2 |
| RS35963548 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS35964044 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS35967690 |
CORO1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to CORO1A deficiency, CORO1A-related disorder |
| RS35969033 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS35969994 |
GUCA1A;GUCA1ANB-GUCA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone dystrophy 3, Cone dystrophy 3 |
| RS35972733 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2D, SGCA-related disorder |
| RS35973133 |
BMPR1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Brachydactyly, Acromesomelic dysplasia 3 |
| RS35976098 |
AP3B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 2, Autoinflammatory syndrome |
| RS35977354 |
LRBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS35978122 |
SLC39A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, spondylocheirodysplastic type |
| RS35983258 |
HBG1
|
Health Risk |
Pathogenic |
Hereditary persistence of fetal hemoglobin, Hereditary persistence of fetal hemoglobin |
| RS35984312 |
FANCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group G |
| RS35985869 |
SKIC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS35991093 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS35993655 |
HBA1
|
Health Risk |
Likely pathogenic |
HEMOGLOBIN TUNIS-BIZERTE, alpha Thalassemia |
| RS35993949 |
CPA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial temporal lobe epilepsy 5, Global developmental delay |
| RS35993958 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS35996658 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrin deficiency, Citrullinemia type II |
| RS35997415 |
TCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS35999761 |
MCPH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 1, primary |
| RS36001797 |
RAG2
|
Health Risk |
Likely pathogenic |
Histiocytic medullary reticulosis, Severe combined immunodeficiency |
| RS36002764 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS36007394 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS36008922 |
HBB
|
Health Risk |
Pathogenic |
HEMOGLOBIN BRISTOL, HEMOGLOBIN ALESHA |
| RS36011345 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS36015961 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
Beta thalassemia intermedia, HEMOGLOBIN DURHAM-N.C. |
| RS36020563 |
HBB
|
Health Risk |
Pathogenic |
Erythrocytosis, familial |